Route 92 announces US FDA 510(k) clearance for FreeClimb 54 reperfusion system
Route 92 Medical has today announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for the FreeClimb 54 reperfusion system, comprised of...
ESMINT issues ‘call for experts’ to streamline EU medical device certification
The European Society of Minimally Invasive Neurological Therapy (ESMINT) has issued a call for experts in neurointerventions to work with notified bodies over the...
Viz.ai and Nico announce collaboration to improve interventional ICH outcomes
Viz.ai has announced a collaboration with Nico Corporation to improve the lives of patients with intracranial haemorrhages (ICHs), leveraging the former’s artificial intelligence (AI)-powered...
Insightec launches next-generation Exablate Prime neurosurgery platform in Europe
Insightec has announced the CE-mark approval and European launch of Exablate Prime, which the company describes as a “significant enhancement” to its Exablate Neuro...
